|Peer Reviewer||Representation||Consultant||Speaker||Ownership/Partnership/ Principal||Research||Institutional, Organizational, or Other Financial Benefit||Expert Witness|
|Eric Bates||Official Reviewer—ACCF Board of Trustees||None||None||None||None||None|
|Lee A. Fleisher||Official Reviewer—AHA||None||None||None||None||None|
|Graham Nichol||Official Reviewer—AHA||None||None||None|
|Michael Rossi||Official Reviewer—ACCF Board of Governors||None||None||None||None||None||None|
|John Brush||Content Reviewer—ACCF Board of Governors||None||None||None||None||None||None|
|Hector Bueno||Content Reviewer—AHA Council on Quality of Care and Outcomes Research||None||None|
|Pamela S. Douglas||Content Reviewer—ACCF Task Force on Appropriate Use Criteria||None||None||None|
|Joseph P. Drozda||Content Reviewer—ACC Clinical Quality Steering Committee||None||None||None||None||None||None|
|Gregg C. Fonarow||Content Reviewer—AHA Get With The Guidelines||None||None||None||None|
|Jeffrey Geppert||Content Reviewer—statistical expertise||None||None||None||None||None||None|
|Robert C. Guyton||Content Reviewer—ACC/AHA Task Force on Practice Guidelines||None||None||None||None||None|
|Robert C. Hendel||Content Reviewer—Task Force on Appropriate Use Criteria||None||None||None||None|
|Rosemarie B. King||Content Reviewer—AHA Stroke Council Quality and Outcomes Committee||None||None||None||None||None|
|David Nilasena||Content Reviewer—Centers for Medicare and Medicaid Services||None||None||None||None||None|
|Richard Nishimura||Content Reviewer—ACC/AHA Task Force on Practice Guidelines||None||None||None||None||None|
|Harry C. Odabashian, Jr||Content Reviewer—ACCF Board of Governors||None||None||None||None|
|Ileana L. Piña||Content Reviewer—AHA Council on Quality of Care and Outcomes Research||None||None||None|
|Stephen Wallach||Content Reviewer—ACCF Board of Governors||None||None||None||None|
ACCF indicates American College of Cardiology Foundation; AHA, American Heart Association; CIHR, Canadian Institutes of Health Research; DSMC, Data Safety Monitoring Committee; NIH, National Institutes of Health; and NINR, National Institute of Nursing Research.
This table represents the relevant relationships of reviewers with industry and other entities that were disclosed at the time of peer review. It does not necessarily reflect relationships with industry at the time of publication. Names are listed in alphabetical order within each category of review. Participation in the peer review process does not necessarily imply endorsement of this document. A person is deemed to have a significant interest in a business if the interest represents ownership of 5% or more of the voting stock or share of the business entity, or ownership of $10 000 or more of the fair market value of the business entity; or if funds received by the person from the business entity exceed 5% of the person's gross income for the previous year. A relationship is considered to be modest if it is less than significant under the preceding definition. Relationships in this table are modest unless otherwise noted.
↵* Significant (greater than $10 000) relationship.